c-Myc

ADC Related

ADC Antibody ADC Cytotoxin ADC Linker ADCs Drug-Linker Conjugates for ADC
Angiogenesis

5-alpha Reductase ALK Bcr-Abl BTK EGFR FAK FLT3 HER-2 HIF Src Syk VDA VEGFR
Anti-infection

Antibiotic Arenavirus Bacterial CMV EBV Enterovirus Filovirus Fungal Gli HBV HCV HCV Protease HIV HSV Influenza Virus Parasite RABV Reverse Transcriptase RSV SARS-CoV TMV Virus Protease
Apoptosis

Apoptosis ASK Bcl-2 Caspase c-Myc c-RET Cytohesin DAPK Ferroptosis FKBP IAP Mdm2 p53 PD-1 PD-L1 PERK PKD Ras RIP kinase ROS Survivin Thymidylate Synthase TNF Receptor TNFa TRADD
Autophagy

Autophagy LRRK2 Mitophagy OGA ULK
Cell Cycle

Antifolate APC Aurora Kinase BMI-1 CDK Chk c-Myc Eukaryotic Initiation Factor G-quadruplex HDAC HSP Kinesin LIMK Mad2 Microtubule(Tubulin) Mps1 Nucleoside Antimetabolite/Analog Nur77 p21 PAK PERK PFKFB PLK PPAR Ras Rho ROCK SRPK TOPK Topoisomerase Wee1
Cytoskeletal Signaling

Arp2 3 Complex Bcr-Abl Cardiac Myosin Dynamin Gap Junction Protein HSP Integrin Kinesin Microtubule Associated MLCK Myosin PAK TACC3 Wntbeta-catenin
DNA Damage

ATM(ATR) CRISPR(Cas9) DNA alkylator DNA Stain DNA(RNA) Synthesis GAK HDAC HSP Nucleoside Antimetabolite(Analog) OGG1 p97 PARG PARP RAD51 RNR Sirtuin SMN Telomerase Topoisomerase
Endocrinology & Hormones

5-alpha Reductase ACE Adrenergic Receptor Androgen Receptor Aromatase Estrogenprogestogen Receptor Glucocorticoid Receptor GPR Mineralocorticoid Receptor RAAS THR TSH Receptor
Epigenetics

AMPK Aurora Kinase DNA Methyltransferase Epigenetic Reader Domain EZH1 2 HDAC HIF Histone Acetyltransferase Histone Demethylase Histone Methyltransferase JAK MAT MicroRNA MLL Pim PKC Protein Arginine Deiminase Sirtuin Small Interfering RNA (siRNA) SMYD

+MORE

c-Myc

c-Myc related products

Cat No.	Product Name	CAS No.	Product Description
V2724	10074-G5	413611-93-5	10074-G5 is a potent inhibitor of c-Myc-Max dimerization and interaction with an IC50 of 146 μM and with anticancer activities.
V1587	10058-F4	403811-55-2	10058-F4 (10058F4; 10058 F4) is a novel potent and selective c-Myc inhibitor with potential antineoplastic activity.
V129674	AV-9606-129	783309-48-8	AV-9606-129 is a USP28 inhibitor with an IC50 < 1 μM.
V113262	Hydroxyrubicin	73113-90-3	Hydroxyrubicin is an anti-tumor drug.
V138437	KI-CDK9d-32	3054009-82-1	KI-CDK9d-32 is a highly selective and highly active CDK9 PROTAC degrader (DC50: 0.89 nM).
V138459	KL4-219A		KL4-219A is a selective covalently binding degrader of the oncogenic transcription factor MYC.
V142853	PLK1-IN-13	3038489-48-1	PLK1-IN-13 is a selective, orally active PLK1 inhibitor (IC50: 0.27 nM).
V144393	RS47	301655-16-3	RS47 is a selective RelB inhibitor with a Kd value of 1.1 μM.
V144811	SF-3-030	1883721-73-0	SF-3-030 is a highly effective, selective, and non-ATP-competitive ERK1/2 inhibitor.
V144824	SGI-1776-VHL-02	3013618-84-0	SGI-1776-VHL-02 is a stereoselective PIM PROTAC degrader.
V144825	SGI-1776-VHL-02-epimer	3013618-85-1	SGI-1776-VHL-02-epimer is the epimer control compound of SGI-1776-VHL-02.
V145297	STAT3-IN-53	3113051-34-3	STAT3-IN-53 is a STAT3 inhibitor with a Kd value of 6.16 μM.
V145469	SVC112		SVC112 is a translation elongation inhibitor that prevents EF2 from cyclically dissociating from the ribosome, thereby inhibiting the elongation step of translation.
V146201	TNIK-IN-10	3112758-72-9	TNIK-IN-10 is a TNIK inhibitor with an IC50 value of 0.49 nM for human TNIK.
V146695	TZ1104		TZ1104 is a PROTAC-based CDK7 degrader with a half-maximal lethal concentration (DC50) of 0.88 nM.
V147039	VTX-0811		VTX-0811 is a human IgG4 monoclonal antibody (mAb) that targets PSGL1/CD162.
V147087	WDR5-MYC-IN-2	3062125-47-4	WDR5-MYC-IN-2 is a WDR5-MYC protein-protein interaction (PPI) inhibitor with an IC50 of 0.59 μM.
V147205	XY25026		XY25026 is an orally effective LRH-1 inhibitor with an IC50 value of 0.28 μM.
V147206	XY25028		XY25028 is an orally effective LRH-1 inhibitor with an IC50 of 0.30 μM.
V147220	Y-99	2034334-74-0	Y-99 is a PORCN inhibitor with an IC50 value of 155.4 nM for the Wnt/β-catenin signaling pathway.